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Infections during pregnancy have been suggested to be involved in childhood leukemias. We used high-
throughput sequencing to describe the viruses most readily detectable in serum samples of pregnant
women. Serum DNA of 112 mothers to leukemic children was ampliﬁed using whole genome
ampliﬁcation. Sequencing identiﬁed one TT virus (TTV) isolate belonging to a known type and two
putatively new TTVs. For 22 mothers, we also performed TTV ampliﬁcation by general primer PCR
before sequencing. This detected 39 TTVs, two of which were identical to the TTVs found after whole
genome ampliﬁcation.
Altogether, we found 40 TTV isolates, 29 of which were putatively new types (similarities ranging
from 89% to 69%). In conclusion, high throughput sequencing is useful to describe the known or
unknown viruses that are present in serum samples of pregnant women.
& 2012 Elsevier Inc. All rights reserved.Introduction
Several epidemiological characteristics of childhood leukemia
have argued for a possible infectious etiology, notably observed
protective effects of intermittent infections during the ﬁrst year of
life, whole day care during the same period and a marked inverse
risk with birth order (zur Hausen and de Villiers, 2005). In the
model proposed by zur Hausen and de Villiers (2005) one of the
initial events is triggered by a prenatal or perinatal infection.
Proliferation of virus-infected cells and the resulting high load of
the suspected agent is suspected as a risk factor. The protective
effect of childhood intermittent infections, could be mediated via
interferon synthesis that would reduce the viral load of the
suspected agent. These authors also postulate that in-utero or
perinatally acquired chromosomal rearrangements, as identiﬁed
by Greaves and Wiemels (2003), would synergistically co-operate
with the putative leukemogenic agent.
zur Hausen and de Villiers also pointed out that speciﬁc
anelloviruses (TT or torque teno viruses) have characteristics
ﬁtting into the proposed model (zur Hausen and de Villiers,
2005), as these viruses are ubiquitous, are transmitted prenatally,ll rights reserved.
ratory Medicine, Karolinska
e F56, Stockholm, Sweden.respond to interferon synthesis (Nishizawa et al., 2000), and
replicate in progenitor cells of human leukemias, bone marrow
and peripheral blood mononuclear cells (Kanda et al., 1999;
Okamoto et al., 2000b).
Anelloviruses form a large and diverse group of ubiquitous
viruses consisting of Torque teno virus (TTV), Torque teno midi
virus (TTMDV) and Torque teno mini virus (TTMV) (Okamoto,
2009). They have circular single-stranded DNA ranging in size
from 2 to 3.8 kb (Okamoto, 2009). TT virus genomes consist of
two main open reading frames (ORFs), ORF 1 and ORF 2, as well as
several additional smaller ORFs resulting from splicing events
(Jelcic et al., 2004). TTV infections are frequent in humans as well
as in other primates, pigs, dogs and cats (Okamoto et al., 2002).
TTV DNA has been found in several organs and tissues (Okamoto,
2009). Investigations to link the TT viruses to the etiology of
speciﬁc diseases have yielded inconsistent results and no direct
link has been established (Garbuglia et al., 2003; Pineau et al.,
2000; Shiramizu et al., 2002).
We previously analyzed serum samples from mothers of
children with leukemia for the presence of TT virus DNA using
cloning and conventional sequencing (Leppik et al., 2007). Most of
the samples were found to harbor TT virus sequences when the
most-conserved region of the TT virus genome was targeted for
ampliﬁcation (Leppik et al., 2007). Also, many samples contained
rearranged TT virus genomes ranging from 172 bp to full-length
genomes (de Villiers et al., 2009; Leppik et al., 2007).
Table 2
Contigs from our bioinformatics pipelines stratiﬁed by percent identities to closest
related TT virus isolates and group of species.
Species
group
Closest strain with
complete genome
Closest strain or
partial sequence
Number of contigs
o80% Z80
and
o90%
Z90%
TTV 1 JA20 JA20 1 0 0
D. Bzhalava et al. / Virology 432 (2012) 427–434428However, conventional technology used for analyses suffers
from low-throughput and from being inherently biased in detect-
ing only sequences with homology to the PCR primers used. Thus,
in order to be able to pursue further studies on the possible
importance of infections during pregnancy, methodological devel-
opments that both allow unbiased virus detection and rapid
generation of sequencing data are necessary.
High-throughput sequencing allows comprehensive sequen-
cing of the DNA in a sample circumventing prior cloning. This
technology has been instrumental in the discovery of a multitude
of novel viruses in humans (Ekstro¨m et al., 2011; Feng et al., 2008;
Finkbeiner et al., 2009; Towner et al., 2008). We wished to apply
the high-throughput sequencing technology for a comprehensive
analysis of which known and unknown viruses are present in
serum samples of pregnant women.TTV 3 HEL32 HEL32 2 0 0
TTV 3 P/1C1 KC037/1–12G 0 4 10
TTV 3 P/1C1 P/1C1 4 0 0
TTV 3 P/1C1 TX011 0 1 5
TTV 3 TTV-HD1a TTV-HD1a 1 0 0
TTV 3 TTV-HD9y TTV-HD9y 1 0 0
TTV 3 TTV-HD10ay TTV-HD10ay 0 0 1
TTV 3 TTV-HD10by TTV sle1767y 0 0 1
TTV 3 TTV-HD10by TTV-HD10by 1 0 0
TTV 3 TTV-HD10by TTV sle2009y 1 0 0
TTV 3 TTV-HD12dy TTV sle1769y 1 0 0
TTV 3 TTV-HD12dy TTV sle1785y 0 1 0
TTV 3 TTV-HD12by TTV sle1975y 1 0 2
TTV 3 TTV-HD12dy TTV sle1999y 0 0 1
TTV 3 TTV-HD12ey TTV sle2053y 1 0 0
TTV 3 TTV-HD12cy TTV-HD12cy 0 0 2
TTV 3 TTV-HD12ay TTV-HD12ay 0 0 2
TTV 3 TTV-HD12ey TTV-HD12ey 2 0 2
TTV 3 TTV-HD17 Mon_G1 0 0 1
TTV 3 TTV-HD23 TTV-HD23 1 0 0
TTV 3 TTV-HD24 TTV-HD24 4 0 0
TTV 5 TCHN-E TCHN-E 1 0 0
TTV 5 TCHN-C1 TCHN-C1 6 6 0
TTV 7 PMV PMV 0 3 0
TT mini
virus 9
TLMV-NLC030 TLMV-NLC030 1 0 0
TTV 10 JT34F JT34F 0 0 1
TTV 15 5-A 5-A 0 2 3
TTV 13 3 h TTV sle2094y 0 0 1
TTV 13 TCHN-A TTV sle2143y 0 0 1
TTV 13 TCHN-A TCHN-A 2 7 2
TTV 13 TTV-HD20 TTV-HD20 0 1 1
TTV 18 SEN virus H KC199/2–21E 0 1 0
TTV 18 SEN virus H SENV-H Orf2 gene 0 0 2
TTV 19 TTV-HD4 TTV-HD4 0 1 0
TTV 20 TTV 20 L1984 1 0 0
TTV 20 TTV 20 Saa-10 1 0 0
TTV 22 TTV-HD16 TTV sle2412y 0 0 3
TTV 22 TTV-HD16 TTV-HD16 4 9 13
TTV 22 TTV-HD18 TTV-HD18 5 44 9
TTV 22 TTV-HD18 TTV gr 3 ORF2 0 0 4
TTV 22 TTV-HD18 475-3 0 0 1
Total 42 80 68Results
Serum samples of mothers of leukemic children were pooled
in three different pools: pool A-15 mothers from the Finnish
maternity cohort; pool B-78 mothers from the Finnish and 19
from the Swedish maternity cohorts; pool C-22 mothers from the
Finnish and Icelandic maternity cohorts. Before sequencing on
454 Genome Sequencer (454 Life Science, Roche) all the pools of
samples were ampliﬁed by whole genome ampliﬁcation. Pool C
was also subjected to TTV ampliﬁcation by general primer PCR
before sequencing. Pools B and C were also sequenced on 454
Genome Sequencer Junior (454 Life Science, Roche), deﬁned as
pool Bj and pool Cj, respectively. The high-throughput sequencing
reads were classiﬁed as human, bacterial or viral (Table 1). Reads
related to plants, plant viruses, synthetic constructs and other
sequences in GenBank are classiﬁed as ‘‘other’’. We deﬁned
sequences which did not give any hits to known genomes in
GenBank as ‘‘unknown’’ (Table 1). Presence of bacterial related
sequences and sequences classiﬁed as ‘‘other’’ were also present
in negative water controls after 454 GS FLX sequencing. Such
background sequences have been reported to be due to back-
ground reactivity of Phi29 polymerase reaction (Hutchison et al.,
2005). As water controls are uniformly negative for viral
sequences, the presence of the background sequences of bacterial
and ‘‘other’’ origin does not affect the reliability of our report on
the viral sequences.
The Herpesviridae sequences (Table 1) were cytomegalovirus
(CMV) and the papillomaviridae sequences (Table 1) were SIBX-3a
a virus recently cloned in our lab and where puriﬁed plasmid was
sequenced in the same run on the 454 sequencer. Thus, its
presence probably represents contamination. However, no cloned
TT viruses or CMV have ever been present in our laboratory and
these should represent valid presence of these sequences in the
serum samples.Table 1
Number of reads from Genome sequencer classiﬁed by taxonomies.
Pool name Pool A Pool B Pool Bj
Pre-ampliﬁcation treatment MDA MDA MDA
454 Genome sequencer FLX FLX Junior
Total reads 37,600 41,320 44,014
Human 2,702 15,889 16,429
Bacterial 16,566 12,471 11,590
Anelloviridae 141 301 325
Herpesviridae 9 61 23
Papillomaviridae 5 2 0
Viral total 155 364 348
Other 15,652 10,493 9,005
Unknown 2,525 2,103 6,642Assemblies from our bioinformatic pipelines resulted in a total
of 190 non-redundant TTV-related contiguous sequences
(Table 2). Seventy-eight of them had less than 95% similarity to
each other and were considered as putatively different isolates.Pool C Pool Cj Total Negative water control
PCR PCR MDA
FLX Junior FLX
81,254 28,017 23,2205 62,188
43,339 21,062 99,421 1,716
48 19 40,694 32,476
35,054 5,086 40,907 0
0 0 93 0
0 0 7 0
35,054 5,086 41,007 0
1,133 306 36,589 9,646
1,680 1,544 14,494 18,350
D. Bzhalava et al. / Virology 432 (2012) 427–434 429Fifty-eight of the putative isolates produced TTV proteins of Z60
aa length after a six frame translation. Forty-six of these contigs
were able to produce ORF1, while 12 contigs produced only ORF2,
ORF3 and ORF4 proteins. None of the contigs reported in this
study contained the GC-rich ‘‘non-coding’’ region present in the
majority of Anellovirus genomes (Fig. 1). Although reported
contigs did not systematically terminate just before the GC-rich
region, their absence is probably due to lack of ampliﬁcation of
GC-rich amplicons by 454 GS FLX system (Grossmann et al., 2011;
Rodrigue et al., 2009).
Out of 46 putative TTV isolates with coding capacity of Z60 aa
ORF1 protein, 40 overlapped with Z80% of their length to ORF1
and were selected for further analysis (Table 3). Eleven of them
shared Z90% similarity to already known TTV ORF1 DNA
sequence and were classiﬁed as known types (Table 3). Twenty-
nine contigs had less than 90% similarity and thus were classiﬁed
as putatively new TTV types (Table 3). The new sequences were
numbered using the preﬁx ‘‘TTV-S’’. A phylogenetic analysis of
how the putatively novel TTV-S types relate to previously known
types, revealed that no less than nine of the TTV-S sequences
clustered in new phylogenetic branches only distantly related to
TTV13 (Fig. 2).
Nucleotide sequences of putative new TTV-S types were
deposited in GenBank under the following accession numbers:
TTV-S1, JQ732204; TTV-S2, JQ732215; TTV-S4, JQ732227; TTV-S5,
JQ732228; TTV-S6, JQ732229; TTV-S7, JQ732230; TTV-S8,
JQ732231; TTV-S9, JQ732232, TTV-S10, JQ732205; TTV-S11,
JQ732206; TTV-S12, JQ732207; TTV-S13, JQ732208; TTV-S14,
JQ732209; TTV-S15, JQ732210; TTV-S16, JQ732211; TTV-S17,
JQ732212; TTV-S18, JQ732213; TTV-S19, JQ732214; TTV-S20,
JQ732216; TTV-S22, JQ732217; TTV-S23, JQ732218; TTV-S24,
JQ732219; TTV-S25, JQ732220; TTV-S26, JQ732221; TTV-S27,
JQ732222; TTV-S28, JQ732223; TTV-S29, JQ732224; TTV-S31,
JQ732225; TTV-S30, JQ732226.
Selected contigs with 80% similarity or above to each other
were considered as the same putative species and were grouped
together producing 27 putative subspecies clusters. Contigs simi-
lar to each other with Z65% were clustered in three putative
species clusters.
The majority of the TTV related contigs classiﬁed as known or
putative new types were detected in pool C (TTV ampliﬁcation by
general primer PCR). One new TT virus ‘‘TTV-S11’’ with 80%
similarity to the TCHN-A isolate was present in both pool B and
C, as well as in a re-sequencing of pool B (Pool Bj) (sequenced
without prior PCR) with the 454 Genome Sequencer JuniorFig. 1. Blue line represents average GC percent of TT virus genomes on 120 bp slid
represented by all 190 non-redundant TTV related and 78 putative isolates, respective
prototype TTV isolate TA278. Dark bold lines show positions of NG133 and NG352 prim
the reader is referred to the web version of this article.)(Table 3). In pool A (sequenced without prior PCR), we identiﬁed
an isolate ‘‘Known5’’, closely related to isolate TTV-HD20 and a
putatively novel TTV type ‘‘TTV-S31’’, related to TLMV-NLC030
(Table 3).
Several sequences classiﬁed as known or putatively new TTV
types showed different percent similarity to the most closely
related TT viruses in GenBank for different parts of their genomes.
In some cases these parts had opposite sense sequences when
compared to available Anellovirus genomes, suggesting the pre-
sence of genome rearrangement(s) (Table 3). To classify them as
known or putative new types, we considered only the part with
the longest overlap to the TTV ORF1 DNA sequence.
Analyses for conserved protein signatures in full-length
genomes of Anelloviruses deposited in GenBank conﬁrmed the
presence of all previously reported motifs (Hijikata et al., 1999;
Mushahwar et al., 1999; Niagro et al., 1998; Noteborn and Koch,
1995; Okamoto et al., 2000a). An arginine-rich N-terminus was
present in six of the putative new ‘‘TTV-S’’ sequences (Fig. 3). Five
TTV-S sequences harbored the Rep motif FTL, whereas FTL was
degenerated as FSL in three other TTV-S sequences (Fig. 3).
Another Rep motif, YXXK, was identiﬁed in 14 TTV-S sequences
(Fig. 3). A putative ORF2 protein with the conserved motif W-X7-
H-X3-C-X1-C-X5-H was identiﬁed in only one TTV-S sequence,
TTV-S18, (Fig. 3). Other reported conserved protein signatures in
the C-terminals of ORF3 and ORF4 were not present in any of the
putative new ‘‘TTV-S’’ sequences described in this study. We
identiﬁed sixteen contigs which had Z90% identity to sequences
described by Leppik et al. (2007) (Table 2). Three of them
possessed Z60 aa ORF1 protein and overlapped Z80% of their
length with TTV ORF1 DNA (Table 3).Discussion
We report the identiﬁcation of 40 TTV types, including 29
putatively new virus types, in the serum samples of mothers of
leukemic children. Analysis of the translation proﬁles of the
putative new TTV-S sequences revealed at least one conserved
protein signature presumed to be unique for TTVs (Mushahwar
et al., 1999; Niagro et al., 1998; Okamoto et al., 2000a) in the
majority of the new TTV-S sequences, supporting that these
viruses belong to the TTV family.
Our study supports that deep sequencing of the spectrum of
viruses present in human sera is feasible and suggests that theing window. Green and red lines show how many times TT virus genome was
ly according to blast hits. Arrows show position of corresponding ORFs from the
ers, respectively. (For interpretation of the references to color in this ﬁgure legend,
Table 3
TTV-related contigs selected as putative new or known types.
Group
Z65%
Group
Z80%
Sequence name
(o95%)
Length New/known Species group Closest strain or partial sequence Closest strain with complete genome Found in
Name % identity % coverage Name % identity % overlap Start position End position
1 1 Known1 1497 Known type TTV3 TTV-HD10ab 94 99 TTV-HD10ab 94 99 787 2281 C
2 Known2 328 Known type TTV3 TX011 93 71 P/1C1 76 71 697 932 C
3 Known3 954 Known type TTV3 TX011 96 76 P/1C1 72 96 226 1144 Cj
TTV-S1 1026 Putative new type TTV3 TTV-HD12eb 70 98 TTV-HD12eb 70 98 1440 2460 C
TTV-S2a 991 Putative new type TTV3 P/1C1 73 95 P/1C1 73 95 567 1515 C
TTV-S4 536 Putative new type TTV3 TTV-HD23 71 98 TTV-HD23 71 98 1682 2213 C
TTV-S5 434 Putative new type TTV3 TTV sle1975b 75 99 TTV-HD10bb 75 99 736 1169 C
4 TTV-S6a 525 Putative new type TTV3 TTV-HD1a 77 74 TTV-HD1a 77 74 920 1311 C
5 TTV-S7 1081 Putative new type TTV5 TCHN-C1 76 99 TCHN-C1 76 99 505 1570 C
6 TTV-S8 1144 Putative new type TTV5 TCHN-C1 70 99 TCHN-C1 70 99 920 2066 C
7 TTV-S9 567 Putative new type TTV5 TCHN-C1 71 98 TCHN-C1 71 98 1748 2308 C
8 TTV-S10a 446 Putative new type TTV5 TCHN-C1 75 94 TCHN-C1 75 94 2190 2627 C
2 9 TTV-S11 2146 Putative new type TTV13 TCHN-A 80 100 TCHN-A 80 100 373 2515 B, Bj, C
TTV-S12 2017 Putative new type TTV13 TCHN-A 80 100 TCHN-A 80 100 125 2154 C
TTV-S13a 584 Putative new type TTV13 TCHN-A 81 96 TCHN-A 81 96 1690 2276 C
10 Known4 665 Known type TTV13 TCHN-A 93 99 TCHN-A 93 99 1971 2633 C
Known5 656 Known type TTV13 TTV-HD20 95 99 TTV-HD20 95 99 377 1028 A,C
TTV-S14 668 Putative new type TTV13 TCHN-A 83 100 TCHN-A 83 100 1656 2323 C
TTV-S15 591 Putative new type TTV13 TCHN-A 83 100 TCHN-A 83 100 1158 1747 C
TTV-S16 493 Putative new type TTV13 TCHN-A 86 99 TCHN-A 86 99 1727 2217 C
11 Known6 574 Known type TTV13 TTV sle2094b 97 100 3 h 72 95 602 1143 C
12 TTV-S17 391 Putative new type TTV15 5-A 84 97 5-A 84 97 1030 1409 C
13 Known7 427 Known type TTV18 SEN virus 96 100 SEN virus 96 100 517 943 C
14 TTV-S18 1965 Putative new type TTV20 TTV20 70 100 TTV20 70 100 119 2120 C
15 TTV-S19 594 Putative new type TTV20 L1984 76 99 TTV20 76 99 1884 2474 C
16 Known8 1064 Known type TTV22 TTV-HD16 90 95 TTV-HD16 90 95 226 1260 C
Known9 392 Known type TTV22 TTV-HD18 91 86 TTV-HD18 91 86 799 1136 C
TTV-S20 1252 Putative new type TTV22 TTV-HD18 83 99 TTV-HD18 83 99 1561 2806 C
TTV-S22 402 Putative new type TTV22 TTV-HD18 84 97 TTV-HD18 84 97 856 1244 C
17 TTV-S23a 613 Putative new type TTV22 TTV-HD18 73 84 TTV-HD18 73 84 1058 1594 C
18 TTV-S24a 485 Putative new type TTV22 TTV-HD18 83 73 TTV-HD18 83 73 515 886 C
19 TTV-S25 506 Putative new type TTV22 TTV-HD16 87 99 TTV-HD16 87 99 1645 2145 C
20 Known10 451 Known type TTV22 TTV sle2412y 96 77 TTV-HD16 88 77 2290 1943 C
21 TTV-S26a 425 Putative new type TTV22 TTV-HD16 75 61 TTV-HD16 75 61 1787 2058 C
22 TTV-S27a 429 Putative new type TTV22 TTV-HD18 83 59 TTV-HD18 83 59 1686 1939 C
23 TTV-S28a 350 Putative new type TTV22 TTV-HD18 70 93 TTV-HD18 70 93 1371 1696 C
24 TTV-S29a 325 Putative new type TTV22 TTV-HD16 85 51 TTV-HD16 85 51 2283 2463 C
25 TTV-S30a 327 Putative new type TTV22 TTV-HD18 89 89 TTV-HD18 89 89 976 1265 C
26 Known11a 343 Known type TTV22 475-3 95 55 TTV-HD18 100 85 879 1095 C
3 27 TTV-S31 327 Putative new type TT mini virus 9 TLMV-
NLC030
69 100 TLMV-
NLC030
69 100 1895 2224 A
a Putative rearranged TTV molecule.
b Sequences described in Leppik et al., 2007. In vivo and in vitro intragenomic rearrangement of TT viruses. J. Virol. 81, 9346–9356.
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Fig. 2. A Bayesian tree based on the 29 putative novel TTV-S sequences and
complete genomes of representative isolates of 29 TTV species groups.
D. Bzhalava et al. / Virology 432 (2012) 427–434 431methodology could be generally useful in prospective epidemio-
logical studies of virus-disease associations.
However, the HTS technology also has limitations. The
un-translated region of TT virus genomes contains an extremely
GC-rich fragment, approximately 120 nucleotides in length (Miyata
et al., 1999). This region was not identiﬁed in any sequence in the
present study. The emulsion PCR step for standard 454 GS FLX
chemistry laboratory procedures lacks efﬁcient ampliﬁcation of
highly GC-rich amplicons and thus GC-rich regions might be
underrepresented (Grossmann et al., 2011; Rodrigue et al., 2009).
Another limitation of the 454 GS FLX platform is base calling
accuracy of homopolymer DNA segments which are error prone
(Magi et al., 2010).
We have previously isolated intragenomic rearranged subviral
TTV genomes from serum samples (Leppik et al., 2007). These
subviral TTV molecules constituted varying numbers of partial
fragments (arranged either in sense or antisense) of a TTV genome
(Leppik et al., 2007). Single nucleotide differences between full-
length isolates of the same TTV type often lead to two or more
putative ORF1s (Leppik et al., 2007). Similar, putative intrage-
nomic rearranged TTV molecules were also identiﬁed in the
present study.
We used stringent assembly parameters in the MIRA assem-
bler and investigated possible mis-assemblies for each sequence
by assessing consensus quality scores, genome organization and
frame shift errors. However, the possibility that assembly algo-
rithms may construct erroneous ‘‘chimeric’’ contigs of different
sequences from different TTV types cannot be excluded. Thiswould result in putatively rearranged TTV molecules being
chimeric due to misassembly. 454 GS FLX sequencing technology
is susceptible to indel-type errors (Margulies et al., 2005) that
may introduce frame shifts in coding regions. These latter errors
may also have led to the smaller ORFs in putative rearranged TTV
sequences presented here. For some of the putative novel TTV
types reported in this study, we obtained subgenomic sequences
which are not overlapping, and some of these may represent
different parts of the same TTV genome. Certainty about the
correct classiﬁcation of the novel putative viruses can only be
obtained by cloning and sequencing of the full viral genomes.
Considering that TT viruses are probably among the most
common chronic human viral infections and the most genetically
diverse viral group infecting humans, there has been relatively
little attention to development of an efﬁcient technology for the
study of these viruses. Our ﬁndings that extend the extreme
genetical diversity of TTVs raise the possibility that, even if most
TTV infections are harmless, maybe a subset of genotypes in a
subset of children might be pathogenic. This hypothesis will be
possible to pursue using the methodology of the present paper.Conclusions
We have performed a comprehensive description of both
known and unknown viruses that are most readily detectable in
serum samples from pregnant women. The wide diversity of TT
viruses detected argues that HTS technology will be required for
obtaining a comprehensive description of the viruses present in
human serum samples in future epidemiological studies investi-
gating the role of TTV in human disease.Materials and methods
Data sources and patient identiﬁcation
The Maternity Cohorts in Finland, Iceland and Sweden contain
about two million serum samples from more than 98 percent of
all pregnant women (approximately 1.5 million women). Samples
are collected at maternity care units at 8–14 weeks of gestation,
for screening of congenital infections (Pukkala et al., 2007). All
samples have been stored at 20 1C to 25 1C (Pukkala et al.,
2007).
Population-based national cancer registries were established
in the Nordic countries in the 1940s and 1950s and are considered
to have a consistently high degree of comparability and comple-
teness over time (Mattsson and Wallgren, 1984; Tulinius et al.,
1992).
All children with childhood leukemia were identiﬁed from the
population-based cancer registries diagnosed between 1983 and
2006 in Finland (929 children), 1997 and 2005 in Iceland (32
children), 1987 and 2006 in Sweden (Ska˚ne Region) (124 chil-
dren). Mothers of these children were identiﬁed through over-
generation linkages between cancer registries, national popula-
tion registries and maternity cohorts. Altogether 685, 20 and 103
serum samples taken during the index pregnancy from mothers
whose children developed childhood leukemia were available
from Finnish, Icelandic and Swedish (Ska˚ne Region) maternity
cohorts, respectively.
Sample preparation
Separation of viral capsids from human chromosomes was
done using ultracentrifugation. Optiprep density gradient med-
ium (Sigma) was used in concentrations of 39%, 33% and 27% as
Fig. 3. Comparison of the deduced amino acid sequences of reported sequences at Table 3. In the left and right of aa sequences are shown beginning and end positions,
respectively. (A) The 100-aa N-terminal sequences in the putative ORF1 (Mushahwar et al., 1999; Niagro et al., 1998) (de novomotif ﬁnding using GLAM2 from MEME suite
(Bailey et al., 2009)). (B) Two of the four conserved amino acid sequence motifs of the putative Rep protein encoded by ORF1 that may be involved in rolling-circle DNA
replication (Mushahwar et al., 1999; Niagro et al., 1998) (pattern matching using fuzzpro from EMBOSS package (Rice et al., 2000)). (C) Conserved amino acid sequence
motif at ORF2 (Hijikata et al., 1999; Noteborn and Koch 1995) (pattern matching using fuzzpro from EMBOSS package (Rice et al., 2000).
D. Bzhalava et al. / Virology 432 (2012) 427–434432described by Buck et al. (2004). Every gradient layer had a volume
of 300 ml. After adding a serum sample to the top of the gradient,
the 5 ml polyallomer ultracentrifuge tube was overlaid with
standard PBS. Use of ultracentrifugation gradients to enrich for
viral particles is likely to have caused an underestimation of
enveloped viruses as they are likely to stay on top of the gradient.
Ultracentrifugation gradients were used for enrichment as the
prime suspected agent of interest (TT viruses) are non-enveloped.
Centrifugation was performed with Sorvall Discovery M120 SE
centrifuge and with swing-out rotor S52-ST at 50,000 g for 3½ h.
After the centrifugation, the bottom of the polyallomer tube was
punctured with a needle and fractions collected. The ﬁrst 100 ml
fraction was discarded as containing human DNA, the next 350 ml
fraction was collected and DNA extracted using a standard SDS/
Proteinase K protocol (Sambrook and Russell, 2001). As a control
experiment to determine which fractions are most likely to
contain virus particles, we added 5 ng (about 150 million parti-
cles) HPV 16 pseudovirions with SEAP reporter plasmid to 60 ml
human serum. Here, 18 fractions of 50 ml each were collected
after the centrifugation. DNA was extracted from the fractions
using the standard SDS/Proteinase K protocol as above and PCR
ampliﬁcation using speciﬁc primers for the b-globin gene (Hazard
et al., 2006) and the SEAP plasmid, performed on each fraction.
The PCR reaction (25 ml) for the SEAP gene included 2.5 ml sample,
0.5 mM of each primer (SEAP-F: 50-CAGGTTCAGGGGGAGGTGTGG-
GAGG-30; SEAP-R: 50-GATACCGCTCGCCGCAGCCGAACGAC-30)
(Cybergene), 200 mM of each dNTP (Fermentas), 3.5 mM MgCl2
(Applied Biosystems), 1 Buffer II (Applied Biosystems) and
0.625 U AmpliTaq Gold DNA polymerase (Applied Biosystems).
Fractions 3 to 9 contained the SEAP plasmid and were free from
human DNA.The samples were pooled in three different pools, A, B and C. In
pool A, samples from mothers of 15 leukemic children from the
Finnish maternity cohort, which were initially positive for
Epstein–Barr virus (EBV) IgM and IgG (Lehtinen et al., 2003) but
proved to be IgM negative in a follow-up study (Tedeschi et al.,
2009), were mixed (15 ml/sample) and density gradient ultracen-
trifugation was performed as described above.
Three ml per sample from 78 mothers from the Finnish and 19
from the Swedish maternity cohorts were mixed into pool B. They
were mothers of children diagnosed with childhood leukemia
under the age of two years. The viral particles were separated
from human DNA using density gradient ultracentrifugation as
described above and viral DNA extracted using MagNA Pure total
nucleic acid (Roche). Samples for pool A and B were then
subjected to whole genome ampliﬁcation using GenomiPhi High
Yield (GE Healthcare) following the manufacturer’s instructions
with some modiﬁcations. Five ml of template DNA was mixed
with 22.5 ml sample buffer and 1 ml 10 BSA (New England
Biolabs). The mixture was denatured at 95 1C for 3 min and
thereafter cooled to 4 1C on ice. To each sample, 22.5 ml reaction
buffer and 2.5 ml enzyme mix was added and the following steps
were performed: incubation for 7 h at 30 1C, inactivation for
10 min at 65 1C, dilution 1:2 in TE buffer (10 mM Tris, pH 8,
1 mM EDTA) and shaking at 500 rpm at 4 1C for 15 h.
For pool C, 10 ml/sample from 22 patients from the Finnish and
Icelandic maternity cohorts were pooled and extracted by MagNA
Pure total nucleic acid (Roche Applied Bioscience). These were
mothers of children diagnosed with childhood leukemia under
the age of 1.5 years. Presence of TTV in these samples had
previously been analyzed by conventional methods (Leppik
et al., 2007). To increase the template mass, the samples were
D. Bzhalava et al. / Virology 432 (2012) 427–434 433ampliﬁed by GenomiPhi High Yield (GE Healthcare) using the
modiﬁed protocol described above. In the Pool C, presence of TTV
was analyzed by Expand long template PCR System (Roche
Applied Biosustems) using the primers NG133-long PCR: CTC
AGC CAT TCG GAA GTG CAC TTA C and NG352-long PCR: CTG GCC
GGG CYA TGG GCA AGG CTC, following the manufacturer’s
instructions for System 1 and denaturation at 94 1C for 2 min;
2 cycles with a denaturation at 94 1C for 10 s, annealing at 64 1C
for 30 s and elongation at 68 1C for 5 min; thereafter 2 cycles of
each annealing temperature of 62 1C, 60 1C, 58 1C and 56 1C with
otherwise the same parameters as for previous cycles; 30 cycles
of 94 1C for 15 s, 63 1C for 30 s and elongation at 68 1C for 4 min
with an additional 20 s/cycle and a ﬁnal step at 68 1C for 10 min.
The PCR mixture was puriﬁed by QIAquick PCR Puriﬁcation Kit
Protocol (QIAgen).
The three pools were sequenced with the 454 technology on a
GS FLX platform, using multiplex identiﬁers (MIDs), included in
the 454 adaptors, to assign the sequences obtained to the
originating sample. Pool B and pool C were also sequenced using
the 454 GS Junior system (pool Bj and pool Cj). The 454 GS Junior
obtains longer sequences as it uses the Titanium chemistry that
was at the time not available for the GS FLX platform, but has
lower sequencing depth capacity.Analysis of sequences
Sequence reads from the 454 Genome Sequencer (454 Life
Science, Roche) were trimmed for tails containing ambiguous
bases (Ns). As ambiguous bases we deﬁned nucleotides which had
Phred quality score less than 30. A Phred quality score of 30 is
equivalent to a base calling accuracy of 99.9% (1 error in 1000
bases) (Ewrin and Green, 1998). After the removal of primer
sequences sequence reads with the length of more than 80 bp
having less than 20% of ambiguous bases were selected for further
analysis with two separate bioinformatic pipelines: (a) Selected
reads were screened for human, bacterial and viral DNA using
SAHHA2 software (Ning et al., 2001). Reads with at least 95%
identity over 75% of their length to human and bacterial DNA
were removed from further analysis. Remaining sequences were
processed for assembly of contiguous sequences (contigs). (b)
From the reads selected as above, we predicted TTV coding
sequences by the gene ﬁnding algorithm Glimmer (Delcher
et al., 1999). The Glimmer algorithm was ﬁrst trained on a set
of all TTV coding sequences from GenBank. All predicted TTV
coding sequences were processed for assembly of contiguous
sequences (contigs).
Genome assembly was performed de novo using the sequence
assembly software MIRA (Chevreux et al., 2004) (with the para-
meters ‘ job¼denovo, genome, accurate, 454 454_SETTINGS AL:
mo¼40 AL:mrs¼98 AL:egp¼yes AS:ardct¼3 CO:mrpg¼4
CL:qcmq¼30 CL:bsqcmq¼600). In assembled contigs, base pairs
that made from consensus of less than ﬁve bases were considered
ambiguous and therefore trimmed off. If a region with ambiguous
bases was in the middle of a contig, the contig was split. Sequences
with the length of Z300 bp were selected for further analysis.
Contigs from pipeline (a) and (b) that were 99% identical
to each other over 99% of their length were clustered using the
Cd-hit algorithm (Li and Godzik, 2006). From each cluster one
representative contig was chosen to make database non-redun-
dant. Non-redundant sequences were compared against GenBank
using the NCBI BLASTn (Altschul et al., 1997) (reward for nucleo-
tide match¼1; penalty of nucleotide mismatch¼1; cost to open a
gap¼0; cost to extend a gap¼2; e-valuere4) to classify them as
non-TTV or TTV-related. If parts of TTV-related contigs (more than
30 nucleotides) were giving hits to other than Anellovirus DNA,these were considered as possible chimeric sequences and
excluded from further analysis.
Protein coding potential of selected sequences was assessed by
translating them into six frames. Contigs with coding capacity of
at least 60 amino acids (aa) related to Anelloviruses were further
processed for clustering using Cd-hit (Li and Godzik, 2006).
Nucleotide sequences with more than 95% percent similarity to
each other over 80% of their length were considered as the same
isolates (Jelcic et al., 2004) and the longest contig was chosen for
further analysis.
ORF1 encompasses at least 60% of the entire genome of
Anelloviruses and is used for taxonomic classiﬁcation (Biagini,
2009, Biagini and de Micco, 2010). To describe putatively new
Anelloviruses, we used contigs which overlapped the ORF1 region
with at least 80% of their length. They were classiﬁed as putative
new types if they shared less than 90% similarity to any TTV ORF1
DNA (Jelcic et al., 2004) present in GenBank by 2012/01/10. Based
on the International Committee on Taxonomy of Viruses
sequences with less than 80% similarity were considered as
different subspecies and sequences with less than 65% as different
species (Biagini and de Micco, 2010).
Deduced aa sequences from putative new TTV-S and known
sequences were analyzed for conserved protein signatures
reported to be characteristic of TTVs. The following were
considered: an arginine-rich N-terminus in ORF1 (Mushahwar
et al., 1999; Niagro et al., 1998) as well as four binding sites for
Rep proteins involved in rolling circle replication, two of which were
reported to be conserved among many plant and animal Circo-
viruses (Mushahwar et al., 1999; Niagro et al., 1998), the protein
motif W-X7-H-X3-C-X1-C-X5-H in ORF2, which was reported to
be common for TTV, TTMVs and chicken anemia virus (Hijikata
et al., 1999; Noteborn and Koch, 1995), a serine-rich domain in
the C-terminal region of ORF3 and E-X8-R-X2-R-X4–6-P-X5–11-
P-X1–8-V-X1-F-X1-L in the C-terminal region of ORF4 (Okamoto
et al., 2000a). For comparison, we also analyzed all amino acid
sequences from the members of Anelloviridae family deposited
with complete genome at GenBank by 2012/01/10 for the same
motifs. Motif analyses were conducted using fuzzpro from EMOSS
package (Rice et al., 2000) and MEME suite (Bailey et al., 2009). All
analyses were performed using in-house (R, Development, Core,
Team, 2010 and python (Langtangen, 2008) scripts.Phylogenetic analysis
BEAST v1.6.2 (Drummond and Rambaut, 2007) was used to
construct a Bayesian Phylogenetic tree. ModelTest v3.7 (Posada
and Crandall, 1998) identiﬁed GTRþG substitution model as the
best ﬁt model based on akaike informationcriterion. The analyses
were initiated with maximum likelihood tree as a starting tree
estimated by PhyML v3 (Guindon and Gascuel, 2003). Four
independent Markov chain Monte Carlo (MCMC) were run under
coalescent tree prior and relaxed uncorrelated lognormal mole-
cular clock for 100,000,000 generations, with a tree logged each
1000th generation. Maximum clade credibility tree was con-
structed after discarding initial 25% generations as a conservative
generalization of the ‘‘burn-in’’ phase.Acknowledgments
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